vs
Kodiak Gas Services, Inc.（KGS）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Kodiak Gas Services, Inc.的季度营收约是Orthofix Medical Inc.的1.5倍（$332.9M vs $219.9M），Kodiak Gas Services, Inc.净利率更高（7.4% vs -1.0%，领先8.4%），Kodiak Gas Services, Inc.同比增速更快（7.5% vs 2.0%），Kodiak Gas Services, Inc.自由现金流更多（$142.0M vs $16.8M），过去两年Kodiak Gas Services, Inc.的营收复合增速更高（24.3% vs 8.0%）
Kodiak Gas Services是北美知名的天然气压缩服务供应商，主要服务油气行业上下游客户，提供定制化压缩设备、运维及运营支持，帮助客户优化陆上天然气收集、处理与运输全流程的运营效率。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
KGS vs OFIX — 直观对比
营收规模更大
KGS
是对方的1.5倍
$219.9M
营收增速更快
KGS
高出5.6%
2.0%
净利率更高
KGS
高出8.4%
-1.0%
自由现金流更多
KGS
多$125.2M
$16.8M
两年增速更快
KGS
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $332.9M | $219.9M |
| 净利润 | $24.6M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 26.1% | 0.2% |
| 净利率 | 7.4% | -1.0% |
| 营收同比 | 7.5% | 2.0% |
| 净利润同比 | 29.0% | 92.4% |
| 每股收益（稀释后） | $0.30 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KGSOFIX
| Q4 25 | $332.9M | $219.9M | ||
| Q3 25 | $322.7M | $205.6M | ||
| Q2 25 | $322.8M | $203.1M | ||
| Q1 25 | $329.6M | $193.6M | ||
| Q4 24 | $309.5M | $215.7M | ||
| Q3 24 | $324.6M | $196.6M | ||
| Q2 24 | $309.7M | $198.6M | ||
| Q1 24 | $215.5M | $188.6M |
净利润KGSOFIX
| Q4 25 | $24.6M | $-2.2M | ||
| Q3 25 | $-14.0M | $-22.8M | ||
| Q2 25 | $39.5M | $-14.1M | ||
| Q1 25 | $30.4M | $-53.1M | ||
| Q4 24 | $19.1M | $-29.1M | ||
| Q3 24 | $-5.6M | $-27.4M | ||
| Q2 24 | $6.2M | $-33.4M | ||
| Q1 24 | $30.2M | $-36.0M |
毛利率KGSOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | 37.5% | 68.7% | ||
| Q2 24 | 36.5% | 67.8% | ||
| Q1 24 | 39.4% | 67.5% |
营业利润率KGSOFIX
| Q4 25 | 26.1% | 0.2% | ||
| Q3 25 | 19.9% | -8.3% | ||
| Q2 25 | 30.9% | -7.9% | ||
| Q1 25 | 27.1% | -25.2% | ||
| Q4 24 | 22.3% | -5.3% | ||
| Q3 24 | 20.4% | -9.6% | ||
| Q2 24 | 17.5% | -12.5% | ||
| Q1 24 | 27.9% | -15.6% |
净利率KGSOFIX
| Q4 25 | 7.4% | -1.0% | ||
| Q3 25 | -4.3% | -11.1% | ||
| Q2 25 | 12.2% | -6.9% | ||
| Q1 25 | 9.2% | -27.4% | ||
| Q4 24 | 6.2% | -13.5% | ||
| Q3 24 | -1.7% | -13.9% | ||
| Q2 24 | 2.0% | -16.8% | ||
| Q1 24 | 14.0% | -19.1% |
每股收益（稀释后）KGSOFIX
| Q4 25 | $0.30 | $-0.05 | ||
| Q3 25 | $-0.17 | $-0.57 | ||
| Q2 25 | $0.43 | $-0.36 | ||
| Q1 25 | $0.33 | $-1.35 | ||
| Q4 24 | $0.18 | $-0.76 | ||
| Q3 24 | $-0.07 | $-0.71 | ||
| Q2 24 | $0.06 | $-0.88 | ||
| Q1 24 | $0.39 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2M | $82.0M |
| 总债务越低越好 | $2.6B | — |
| 股东权益账面价值 | $1.2B | $450.0M |
| 总资产 | $4.3B | $850.6M |
| 负债/权益比越低杠杆越低 | 2.12× | — |
8季度趋势，按日历期对齐
现金及短期投资KGSOFIX
| Q4 25 | $3.2M | $82.0M | ||
| Q3 25 | $724.0K | $62.9M | ||
| Q2 25 | $5.4M | $65.6M | ||
| Q1 25 | $1.9M | $58.0M | ||
| Q4 24 | $4.8M | $83.2M | ||
| Q3 24 | $7.4M | $30.1M | ||
| Q2 24 | $3.9M | $26.4M | ||
| Q1 24 | $9.3M | $27.0M |
总债务KGSOFIX
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | $157.2M | ||
| Q2 25 | $2.5B | $157.0M | ||
| Q1 25 | $2.6B | $156.9M | ||
| Q4 24 | $2.6B | $157.0M | ||
| Q3 24 | $2.6B | $118.5M | ||
| Q2 24 | $2.5B | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益KGSOFIX
| Q4 25 | $1.2B | $450.0M | ||
| Q3 25 | $1.3B | $442.5M | ||
| Q2 25 | $1.3B | $458.3M | ||
| Q1 25 | $1.4B | $458.3M | ||
| Q4 24 | $1.4B | $503.1M | ||
| Q3 24 | $1.4B | $525.9M | ||
| Q2 24 | $1.5B | $546.0M | ||
| Q1 24 | $1.1B | $570.3M |
总资产KGSOFIX
| Q4 25 | $4.3B | $850.6M | ||
| Q3 25 | $4.4B | $832.6M | ||
| Q2 25 | $4.4B | $837.2M | ||
| Q1 25 | $4.4B | $823.1M | ||
| Q4 24 | $4.4B | $893.3M | ||
| Q3 24 | $4.5B | $867.9M | ||
| Q2 24 | $4.4B | $882.0M | ||
| Q1 24 | $3.3B | $906.0M |
负债/权益比KGSOFIX
| Q4 25 | 2.12× | — | ||
| Q3 25 | 2.08× | 0.36× | ||
| Q2 25 | 1.89× | 0.34× | ||
| Q1 25 | 1.91× | 0.34× | ||
| Q4 24 | 1.88× | 0.31× | ||
| Q3 24 | 1.86× | 0.23× | ||
| Q2 24 | 1.71× | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $194.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $142.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 42.7% | 7.6% |
| 资本支出强度资本支出/营收 | 15.9% | 4.9% |
| 现金转化率经营现金流/净利润 | 7.91× | — |
| 过去12个月自由现金流最近4个季度 | $284.3M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流KGSOFIX
| Q4 25 | $194.9M | $27.7M | ||
| Q3 25 | $113.4M | $12.4M | ||
| Q2 25 | $177.2M | $11.6M | ||
| Q1 25 | $114.3M | $-18.4M | ||
| Q4 24 | $118.5M | $23.7M | ||
| Q3 24 | $36.9M | $11.7M | ||
| Q2 24 | $121.1M | $9.0M | ||
| Q1 24 | $51.5M | $-18.6M |
自由现金流KGSOFIX
| Q4 25 | $142.0M | $16.8M | ||
| Q3 25 | $10.9M | $2.5M | ||
| Q2 25 | $94.6M | $4.5M | ||
| Q1 25 | $36.8M | $-25.1M | ||
| Q4 24 | $45.2M | $15.2M | ||
| Q3 24 | $-49.7M | $6.3M | ||
| Q2 24 | $4.0M | $-360.0K | ||
| Q1 24 | $-8.6M | $-29.1M |
自由现金流率KGSOFIX
| Q4 25 | 42.7% | 7.6% | ||
| Q3 25 | 3.4% | 1.2% | ||
| Q2 25 | 29.3% | 2.2% | ||
| Q1 25 | 11.2% | -13.0% | ||
| Q4 24 | 14.6% | 7.0% | ||
| Q3 24 | -15.3% | 3.2% | ||
| Q2 24 | 1.3% | -0.2% | ||
| Q1 24 | -4.0% | -15.4% |
资本支出强度KGSOFIX
| Q4 25 | 15.9% | 4.9% | ||
| Q3 25 | 31.7% | 4.8% | ||
| Q2 25 | 25.6% | 3.5% | ||
| Q1 25 | 23.5% | 3.5% | ||
| Q4 24 | 23.7% | 4.0% | ||
| Q3 24 | 26.7% | 2.7% | ||
| Q2 24 | 37.8% | 4.7% | ||
| Q1 24 | 27.9% | 5.6% |
现金转化率KGSOFIX
| Q4 25 | 7.91× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.49× | — | ||
| Q1 25 | 3.76× | — | ||
| Q4 24 | 6.21× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 19.44× | — | ||
| Q1 24 | 1.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KGS
| Other Services | $126.8M | 38% |
| Other | $112.2M | 34% |
| Transferred At Point In Time | $93.8M | 28% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
